Key facts
- ExaCare AI’s last known valuation is $228.0M (Oct 2025).
- It has raised $36.5M; the latest was Early Stage VC ($30.0M) in Oct 2025.
- Notable investors include Insight Partners (New York), Foundation Capital, 1984 Ventures, Bienville Capital, Fractal Software.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ExaCare AI
- ·The full record, as it builds
Funding rounds
No funding rounds for ExaCare AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ExaCare AI
Developer of all-in-one care facility software designed to help assisted living facilities deliver the required care. The company's software is a user-friendly interface that cuts down the administrative burden and increases resident care, which is built specifically for the workflows of assisted living facilities to maintain facility compliance, enabling firms to reduce the burdensome nature of data entry, integration, and data migration for the living facilities.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 40
- Website
- exacare.com/
- Ownership
- Privately Held (backing)
ExaCare AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ExaCare AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ExaCare AI in its N-PORT filings yet. We sweep new filings monthly.